欧州のロボット脳神経外科市場 - 分析と予測（2025年～2035年）

欧州のロボット脳神経外科の市場規模は、2024年には9,310万米ドルとなりました。

同市場は、2035年までに5億8,530万米ドルに達すると予測され、2025年から2035年の予測期間中に17.83％のCAGRで拡大するとみられています。神経疾患の有病率の上昇と、それに伴う高度な手術手技の必要性が、アジア太平洋におけるロボット神経外科市場の成長を促す主な要因となっています。AI対応ガイダンス、リアルタイム画像統合、精密ロボットの進歩により、応用分野が拡大し、成果が高まっています。合併症を減らし回復時間を短縮する低侵襲技術への地域的シフトにより、採用が加速しています。

市場イントロダクション

欧州におけるロボット神経外科市場は、医療専門家がより洗練された技術を使用して増え続ける神経疾患の治療に取り組むにつれて、着実に拡大すると予想されています。外科医は、脳深部刺激療法（DBS）、てんかんマッピング、腫瘍切除などの複雑な治療を、ロボットシステムの比類ない精度により、より少ない組織損傷と高い精度で行うことができます。欧州の確立されたヘルスケアシステム、好意的な支払い政策、低侵襲手術への注目の高まりはすべて、同大陸の産業隆盛に貢献しています。

この地域の高齢化とそれに伴う神経疾患の増加は、高度な外科手術の需要を促進する大きな要因となっています。患者の転帰を改善し回復期間を短縮することに加え、触覚フィードバック、リアルタイム画像統合、AI強化ナビゲーションなどの技術的進歩がロボットアプリケーションの範囲を拡大しています。Monteris Medical、Renishaw、Zimmer Biomet、Medtronicなどの国内外の著名企業は、ワークフロー統合の改善や臨床効果の実証に向け、学術機関と積極的に連携しています。

取得・維持コストの高さ、CEマーキングのためのEU医療機器規制（MDR）基準の厳しさ、専門的な外科医トレーニングの需要などは、好調なペースにもかかわらず、この事業が直面している課題の一部です。しかし、研究開発への継続的な投資と手術センターの認定プログラムの拡大により、こうした困難は軽減されると予想されます。そのため、欧州のロボット脳神経外科市場は、技術革新、規制の調和、より正確で患者中心の医療を求める共通の意欲により、急速な発展が見込まれています。

市場セグメンテーション

セグメンテーション1：地域別

• 欧州

英国

ドイツ

フランス

イタリア

スペイン

その他

欧州のロボット脳神経外科市場動向と促進要因・課題

市場動向

• AIを活用した画像処理とナビゲーション・プラットフォームの統合別精度の向上とエラーの減少
• ロボット工学と拡張現実や触覚フィードバックを組み合わせたマルチモーダルシステムの成長
• 低侵襲脳神経外科手術用フレームレス定位ロボット（ROSAなど）の使用増加
• ロボットアームの小型化とモジュール化により、多様な手術室環境での柔軟な展開が可能

主な促進要因

• 神経疾患（パーキンソン病、てんかん、脳腫瘍など）の有病率の上昇
• 好意的な償還政策と拡大するヘルスケア予算
• 手術時間の短縮、精度の向上、患者の転帰の改善を示す臨床的証拠
• 脳神経外科専門センターおよびトレーニングプログラムの成長

主な課題

• 取得および維持コストが高いため、小規模病院での利用が制限されます。
• 学習曲線が険しく、訓練を受けた脳神経外科ロボットチームの不足
• 市場参入を遅らせる規制とCEマーキングの複雑さ
• レガシーITシステムとの統合のハードルとサイバーセキュリティの懸念

当レポートでは、欧州のロボット脳神経外科市場について調査し、市場の概要とともに、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 欧州ロボット脳神経外科市場：業界見通し

• 動向：現状と将来への影響評価
  • ロボット脳神経外科手術の導入増加
  • 市場参入企業間の多数のコラボレーション
  • 製品発売と規制承認の増加
• サプライチェーンの概要
• 規制の枠組み
  • 欧州連合（EU）
  • 英国
• 価格分析
• 資金調達シナリオ
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第2章 ロボット脳神経外科市場（地域別）、100万米ドル、2023年～2035年

• 地域のサマリー
• 欧州
  • 地域概要
  • 市場成長促進要因
  • 市場成長抑制要因
  • 手技件数
  • ドイツ
  • スペイン
  • 英国
  • その他

第3章 市場- 製品プロファイル

• Renishaw plc
• Zimmer Biomet Holdings, Inc.

第4章 市場-競合ベンチマーキングと企業プロファイル

• 製品ベンチマーク
• 主要戦略と開発
• 企業プロファイル
  • Brainlab AG
  • Renishaw plc
  • Medtronic plc

第5章 調査手法

List of Figures

• Figure 1: Europe Robotic Neurosurgery Market (by Scenario), $Million, 2024, 2028, and 2035
• Figure 2: Robotic Neurosurgery Market, $Million, 2023 and 2035
• Figure 3: Europe Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
• Figure 4: Robotic Neurosurgery Literature Published, January 2015 to April 2025
• Figure 5: Supply Chain and Risks within the Supply Chain
• Figure 6: EU Classification
• Figure 7: NHS Classification
• Figure 8: Impact Analysis of Market Navigating Factors, 2024-2035
• Figure 9: Global Incidences of Neurological Disorders, Thousands, 2018-2021
• Figure 10: Global Prevalence of Neurological Disorders (by Type of Neurological Disease), Thousands, 1990-2019
• Figure 11: Prevalence of Parkinson's Disease, Region (2016-2021)
• Figure 12: Timeline of the FDA Approvals for Various Robotic Neurosurgery Systems
• Figure 13: Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
• Figure 14: Europe Robotic Neurosurgery Market, $Million, 2023-2035
• Figure 15: Europe Robotic Neurosurgery Market, Installed Base, 2023-2035
• Figure 16: Europe Robotic Neurosurgery Market, Unit Sold, 2023-2035
• Figure 17: Incidences of Neurological Disorders in Germany, 2018-2021
• Figure 18: Germany Robotic Neurosurgery Market, Procedure Volume, 2023-2035
• Figure 19: Germany Robotic Neurosurgery Market, $Million, 2023-2035
• Figure 20: Incidences of Neurological Disorders in France, 2018-2021
• Figure 21: France Robotic Neurosurgery Market, Procedure Volume, 2023-2035
• Figure 22: France Robotic Neurosurgery Market, $Million, 2023-2035
• Figure 23: Incidences of Neurological Disorders in Italy, 2018-2021
• Figure 24: Italy Robotic Neurosurgery Market, Procedure Volume, 2023-2035
• Figure 25: Italy Robotic Neurosurgery Market, $Million, 2023-2035
• Figure 26: Incidences of Neurological Disorders in Spain, 2018-2021
• Figure 27: Spain Robotic Neurosurgery Market, Procedure Volume, 2023-2035
• Figure 28: Spain Robotic Neurosurgery Market, $Million, 2023-2035
• Figure 29: Incidences of Neurological Disorders in U.K., 2018-2021
• Figure 30: U.K. Robotic Neurosurgery Market, Procedure Volume, 2023-2035
• Figure 31: U.K. Robotic Neurosurgery Market, $Million, 2023-2035
• Figure 32: Rest-of-Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
• Figure 33: Rest-of-Europe Robotic Neurosurgery Market, $Million, 2023-2035
• Figure 34: Strategic Initiatives, January 2022-April 2025
• Figure 35: Data Triangulation
• Figure 36: Top-Down and Bottom-Up Approach
• Figure 37: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Competitive Landscape Snapshot
• Table 3: Robotic Neurosurgery Market Trend Analysis
• Table 4: Some of the Partnerships and Collaborations in the Robotic Neurosurgery Market
• Table 5: Some of the Product Launch and Regulatory Approvals in the Robotic Neurosurgery Market
• Table 6: Costs of Neurosurgery Robotic Systems
• Table 7: Funding Scenario of Neurosurgery Robotic Systems
• Table 8: Comparison of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
• Table 9: Comparison Between Various Navigation Systems Cost Breakdown of Robotic Neurosurgery Systems
• Table 10: Robotic Neurosurgery Market (by Region), $Million, 2023-2035
• Table 11: Europe Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
• Table 12: Incidences of Neurological Disorders in Germany, By Disease Type, 2018-2021
• Table 13: Incidences of Neurological Disorders in France, By Disease Type, 2018-2021
• Table 14: Incidences of Neurological Disorders in Italy, By Disease Type, 2018-2021
• Table 15: Incidences of Neurological Disorders in Spain, By Disease Type, 2018-2021
• Table 16: Incidences of Neurological Disorders in U.K., By Disease Type, 2018-2021
• Table 17: Robotic Neurosurgery Market, Product Benchmarking (by Product)
• Table 18: Key Strategies, January 2022-April 2025

This report can be delivered in 2 working days.

Introduction to Europe Robotic Neurosurgery Market

The Europe robotic neurosurgery market is projected to reach $585.3 million by 2035 and estimated $93.1 million in 2024, growing at a CAGR of 17.83% during the forecast period 2025-2035. The increasing prevalence of neurological disorders and the resulting need for sophisticated surgical techniques are major factors driving the growth of the robotic neurosurgery market in Asia-Pacific. Advances in AI-enabled guidance, real-time imagery integration, and precision robots are increasing application areas and enhancing results. Adoption is accelerating due to a regional shift towards minimally invasive techniques that reduce complications and shorten recovery times.

Market Introduction

The market for robotic neurosurgery in Europe is expected to increase steadily as medical professionals use more sophisticated technology to treat the growing number of neurological conditions. Surgeons can execute intricate treatments like deep brain stimulation (DBS), epilepsy mapping, and tumour resections with less tissue damage and more accuracy because to robotic systems' unmatched precision. Europe's well-established healthcare system, favourable payment policies, and increasing focus on minimally invasive procedures have all contributed to the continent's thriving industry.

The region's ageing population and the rise in neurological illnesses that goes along with it are major factors driving the demand for advanced surgical procedures. In addition to improving patient outcomes and reducing recovery periods, technological advancements like haptic feedback, real-time imaging integration, and AI-enhanced navigation are expanding the range of robotic applications. Prominent regional and international companies, including as Monteris Medical, Renishaw, Zimmer Biomet, and Medtronic, are actively working with academic institutions to improve workflow integration and demonstrate clinical efficacy.

High acquisition and maintenance costs, strict EU Medical Device Regulation (MDR) criteria for CE marking, and the demand for specialised surgeon training are some of the challenges facing the business despite its strong pace. However, it is anticipated that these difficulties will be lessened by continued investments in R&D and expanding surgical centre accreditation programs. The market for robotic neurosurgery in Europe is therefore expected to develop quickly because to innovation, harmonised regulations, and a shared drive for more precise, patient-centered care.

Market Segmentation

Segmentation 1: by Region

• Europe

U.K.

Germany

France

Italy

Spain

Rest-of-Europe

Europe Robotic Neurosurgery Market Trends, Drivers and Challenges

Market Trends

• Integration of AI-driven imaging and navigation platforms for enhanced precision and reduced errors
• Growth of multi-modal systems combining robotics with augmented reality and haptic feedback
• Increasing use of frameless stereotactic robots (e.g., ROSA) for minimally invasive neurosurgical procedures
• Miniaturization and modular robotic arms enabling flexible deployment in diverse OR environments

Key Drivers

• Rising prevalence of neurological disorders (e.g., Parkinson's, epilepsy, brain tumors)
• Favorable reimbursement policies and expanding healthcare budgets
• Clinical evidence showing reduced operative time, improved accuracy, and better patient outcomes
• Growth of specialized neurosurgical centers and training programs

Major Challenges

• High acquisition and maintenance costs limiting access for smaller hospitals
• Steep learning curves and shortage of trained neurosurgical robotics teams
• Regulatory and CE-marking complexities delaying market entry
• Integration hurdles with legacy IT systems and cybersecurity concerns

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

• Brainlab AG
• Renishaw plc
• Medtronic plc.

Table of Contents

Executive Summary

Scope and Definition

1 Europe Robotic Neurosurgery Market: Industry Outlook

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
  • 1.1.2 Significant Number of Collaborations among Market Players
  • 1.1.3 Growing Number of Product Launch and Regulatory Approvals
• 1.2 Supply Chain Overview
• 1.3 Regulatory Framework
  • 1.3.1 European Union (EU)
  • 1.3.2 U.K.
• 1.4 Pricing Analysis
• 1.5 Funding Scenario
• 1.6 Market Dynamics
  • 1.6.1 Market Drivers
    • 1.6.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
    • 1.6.1.2 Rising Prevalence of Neurological Disorders
    • 1.6.1.3 Continuous Technological Advancements in Robotic Neurosurgery
  • 1.6.2 Market Restraints
    • 1.6.2.1 High Cost of Investment
    • 1.6.2.2 Lack of Skilled Professionals
  • 1.6.3 Market Opportunities
    • 1.6.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems

2 Robotic Neurosurgery Market (by Region), $Million, 2023-2035

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 Procedure Volume
  • 2.2.5 Germany
  • 2.2.6 Spain
  • 2.2.7 U.K.
  • 2.2.8 Rest-of-Europe

3 Markets - Product Profiles

• 3.1 Renishaw plc
  • 3.1.1 Product Overview
  • 3.1.2 Launch Year
  • 3.1.3 Key Features
  • 3.1.4 Key Parameter
  • 3.1.5 Installed Base
  • 3.1.6 Unit Sold
• 3.2 Zimmer Biomet Holdings, Inc.
  • 3.2.1 Product Overview
  • 3.2.2 Launch Year
  • 3.2.3 Key Features
  • 3.2.4 Key Parameter
  • 3.2.5 Installed Base
  • 3.2.6 Unit Sold

4 Markets - Competitive Benchmarking & Company Profiles

• 4.1 Product Benchmarking
• 4.2 Key Strategies and Development
• 4.3 Company Profiles
  • 4.3.1 Brainlab AG
    • 4.3.1.1 Overview
    • 4.3.1.2 Top Products/Product Portfolio
    • 4.3.1.3 Top Competitors
    • 4.3.1.4 Target Customers
    • 4.3.1.5 Key Personal
    • 4.3.1.6 Analyst View
  • 4.3.2 Renishaw plc
    • 4.3.2.1 Overview
    • 4.3.2.2 Top Products/Product Portfolio
    • 4.3.2.3 Top Competitors
    • 4.3.2.4 Target Customers
    • 4.3.2.5 Key Personal
    • 4.3.2.6 Analyst View
  • 4.3.3 Medtronic plc
    • 4.3.3.1 Overview
    • 4.3.3.2 Top Products/Product Portfolio
    • 4.3.3.3 Top Competitors
    • 4.3.3.4 Target Customers
    • 4.3.3.5 Key Personal
    • 4.3.3.6 Analyst View

5 Research Methodology

• 5.1 Data Sources
  • 5.1.1 Primary Data Sources
  • 5.1.2 Secondary Data Sources
  • 5.1.3 Data Triangulation
• 5.2 Market Estimation and Forecast